A Feasibility Study of an Online Intervention for Sexual Rehabilitation in Prostate Cancer

Sponsor
Nova Scotia Health Authority (Other)
Overall Status
Unknown status
CT.gov ID
NCT01716702
Collaborator
Canada: Beatrice Hunter Cancer Research Institute (Other)
48
1
2
25
1.9

Study Details

Study Description

Brief Summary

Background: Prostate cancer (PCa) is the most common cancer for men. When treated early enough it is typically curable. However, common treatments, such as radical prostatectomy and radiation therapy, often result in significant negative outcomes with regard to sexual, psychological and social function. Both men and partners have identified the need for more information and support to address sexual health concerns after treatment. However, very few sexual rehabilitation interventions have been developed and rigorously assessed.

Purpose: The investigators propose to develop and pilot test a new program to meet the sexual health needs of men with PCa and their partners using an online, professionally facilitated education/support program. The goals of the program are to improve sexual function, intimacy and mood for men and their partners after treatment for localized PCa. The program will be offered through Cancer Chat Canada, an existing and well-tested Canadian platform for professionally facilitated support group programs.

What Participants Can Expect: A total of 24 men and their female partners (48 individuals) will be recruited and assigned to one of two groups. The first group will participate in the program immediately; the second group will be offered the program after a 5-month delay. The decision about which group will start immediately and which later will be made randomly (by chance). Both groups of men and partners will be asked to complete questionnaires three times and, at the end of the program, to provide the researchers feedback about how satisfied they were with the program, the changes they made, things they learned as a result of the program, and suggestions for improving the program. Participants must have access to a computer, an Internet connection and be willing to attend online, chat room meetings each week for 1.5 hours for 6 weeks.

Implications: Sexual rehabilitation is a high need for men affected by PCa, but is difficult to access. The investigators hope to improve access to sexual health care through this study.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Couples Prostate Cancer Support Group
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
A Feasibility Study of an Online Intervention for Sexual Rehabilitation in Prostate Cancer
Study Start Date :
Nov 1, 2012
Anticipated Primary Completion Date :
Dec 1, 2014
Anticipated Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Couples Prostate Cancer Support Group

The participants in the support group will receive 6 weekly online intervention sessions with a professional facilitator. In addition participants will be asked to complete relationship-enhancement exercises and readings in between sessions. Participants will be asked to complete questionnaires at three time points: 1)pre-intervention (baseline) 2) post-intervention (7 weeks), and 3) post intervention (13 weeks).

Behavioral: Couples Prostate Cancer Support Group
The participants in the experimental group will receive 6 weekly online intervention sessions with a professional facilitator. In addition participants will be asked to complete relationship-enhancement exercises and readings in between sessions. In the experimental group, participants will be asked to complete questionnaires at three time points: 1)pre-intervention (baseline) 2) post-intervention (7 weeks), and 3) post intervention (13 weeks). In the waitlist group, participants will not participate in the support group. Participants will be asked to complete questionnaires at three time points: 1)pre-intervention (baseline) 2) post-intervention (7 weeks), and 3) post intervention (13 weeks).

No Intervention: Wait-List Control

Participants will be asked to complete questionnaires at three time points: 1)week 1 2) week 7, and 3) week 13.

Outcome Measures

Primary Outcome Measures

  1. Change in Sexual Function from Baseline to 13 weeks [Pre-Intervention (Week 1); Post-Intervention (Week 7); 3 Months Post-Intervention (Week 13)]

Secondary Outcome Measures

  1. Change in Personal Assessment of Intimacy and Relationships from baseline to 13 weeks [Pre-Intervention (Week 1); Post-Intervention (Week 7); 3 Months Post-Intervention (Week 13)]

Other Outcome Measures

  1. Change in Profile of Mood States Short Form from baseline to 13 weeks [Pre-Intervention (Week 1); Post-Intervention (Week 7); 3 Months Post-Intervention (Week 13)]

    This tool assesses psychological distress across 6 domains: fatigue-inertia, vigor-activity, tension-anxiety, depression-dejection, anger-hostility, and confusion-bewilderment.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Men who have been treated for localized prostate cancer

  • AND men must be 6-36 months post-prostatectomy or radiation (as primary treatment) of prostate cancer

  • Must have a heterosexual, co-cohabiting partner who is willing to participate

  • Must speak and read English

  • Must be able to use a computer and have internet access

Exclusion Criteria:
  • Homosexual couples will not be included in this study

  • Major self-reported psychiatric illness

  • Couples who screen below 30 on the DAS (Dyadic Adjustment Scale)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Capital District Halifax Nova Scotia Canada

Sponsors and Collaborators

  • Nova Scotia Health Authority
  • Canada: Beatrice Hunter Cancer Research Institute

Investigators

  • Principal Investigator: Deborah L McLeod, R.N., Ph.D., Capital District Health Authority & Dalhousie University
  • Principal Investigator: Richard J Wassersug, Ph.D., University of British Columbia
  • Principal Investigator: Karen Fergus, Ph.D., C. Psych., Sunnybrook Odette Cancer Centre & York University
  • Principal Investigator: John Robinson, Ph.D., C. Psych., Tom Baker Cancer Centre & University of Calgary
  • Principal Investigator: John Oliffe, R.N, Ph.D., University of British Columbia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nova Scotia Health Authority
ClinicalTrials.gov Identifier:
NCT01716702
Other Study ID Numbers:
  • CDHA-RS/2013-076
First Posted:
Oct 30, 2012
Last Update Posted:
Mar 14, 2014
Last Verified:
Mar 1, 2014
Keywords provided by Nova Scotia Health Authority
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 14, 2014